Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
51 /100
HIGH RISK
Score updated Oct 27, 2026

FHTX — Foghorn Therapeutics Inc. Dilution Risk Tracker

Track FHTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track FHTX — Get alerts when the score changes →

As of October 27, 2026, Foghorn Therapeutics Inc. (FHTX) has a DilutionWatch DilutionScore of 51/100, rated HIGH dilution risk. Foghorn Therapeutics Inc. has a market capitalization of $122.63M, 59.39M shares outstanding, 105 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
65
📊 Float Risk
40
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
💰 Capital Raise model 15%
• Under 12 months cash (7mo)
🔔 Track FHTX — Get forecast alerts →

Market Data

Market Cap$122.63M
Shares Outstanding59.39M
Float27.41M
Cash$68.08M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore51/100DilutionWatch score record
Shares Outstanding59.39MVerified float table or market cache
Public Float27.41MVerified float table or market cache
Market Cap$122.63MMarket data cache
Cash Runway7.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

FHTX SEC Filing Activity — Last 12 Months

Shares outstanding reported by FHTX on the cover page of its latest 10-K/10-Q: 59.39M as of July 31, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for FHTX in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
8-Kcurrent report (material event)3Oct 01, 2026
10-Kannual report1Mar 11, 2026
10-Qquarterly report2Aug 06, 2026
DEF 14Aproxy statement1Apr 30, 2026
SC 13G/Aamended passive >5% holder filing1Oct 05, 2026
4insider transaction3Jun 25, 2026
3initial insider ownership4Oct 05, 2026

Institutional Holdings

QoQ: ↑ 11.4% shares (2026Q1 vs prior)
105 institutional holders · 46.77M shares
#1 Flagship Pioneering, LLC 12.67M shares
#2 FMR LLC 6.05M shares
#3 BVF INC/IL 5.84M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.46M
Days to Cover1.2
% of Float9.0%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2022-08-09
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual FHTX Dilution Snapshot

Foghorn Therapeutics Inc. (FHTX) has a DilutionScore of 51/100, rated High dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

FHTX's DilutionScore has held steady at 51/100 (High risk) for 89 consecutive days across the tracked period.

Period Score Risk Level Duration
Jul 30 – Oct 27, 202651/100HIGH89 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

FHTX shares outstanding have increased 0.2% from 58.58M (Mar 2026) to 58.71M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 18, 202658.71M27.41M▲ 0.76%
May 17, 202658.71M27.20M▼ 5.20%
May 15, 202658.71M28.69M▲ 0.02%
May 08, 202658.71M28.69M▲ 0.02%
Mar 23, 202658.70M28.68M▲ 0.31%
Mar 14, 202658.58M28.59M▲ 0.21%
Mar 13, 202658.58M28.53M▲ 3.80%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track FHTX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment FHTX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking FHTX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for FHTX
FHTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.